Waters Corporation WAT
433.54
3.24
0.75%
as of 25 Sep
- Market cap
- $42.3B
- P/E
- 108×
Follow WAT
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Waters Corporation (WAT) EV/Sales
As of 25 September 2026, Waters Corporation (WAT) trades at a EV/Sales of 10.1×. Over the past ten years it has ranged from 4.1× (February 2016) to 10.2× (September 2021); the current reading is higher than 100% of that period. That is above the Diagnostics & Research industry median of 5.7× and above the Healthcare sector median of 3.6×.
EV/Sales, daily
Annual
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 7.3× | (7.94%) |
| FY2024 | 7.9× | 9.26% |
| FY2023 | 7.2× | (1.55%) |
| FY2022 | 7.3× | (14.56%) |
| FY2021 | 8.6× | 25.77% |
| FY2020 | 6.8× | (3.74%) |
| FY2019 | 7.1× | 22.97% |
| FY2018 | 5.8× | (5.80%) |
| FY2017 | 6.1× | 33.72% |
| FY2016 | 4.6× | (8.22%) |
Quarterly
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 8.9× | 15.85% |
| Mar 2026 | 7.7× | 5.49% |
| Dec 2025 | 7.3× | 22.87% |
| Sep 2025 | 5.9× | (16.76%) |
| 42 more quarters | Free account |
Against its own ten years
Low 4.1×
High 10.2×
Ten-year median
6.4×
Current reading's percentile
100
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| DGX Quest Diagnostics Incorporated compare | 2.7× |
| IQV IQVIA Holdings Inc. compare | 3.5× |
| A Agilent Technologies, Inc. compare | 6.9× |
| MTD Mettler-Toledo International, Inc. compare | 7.9× |
| IDXX IDEXX Laboratories, Inc. compare | 9.1× |
| ILMN Illumina, Inc. compare | 9.3× |
| WAT Waters Corporation | 10.1× |
| GH Guardant Health, Inc. compare | 20.3× |
| NTRA Natera, Inc. compare | 21.6× |
| Diagnostics & Research industry median | 5.7× |
| Healthcare sector median | 3.6× |
| Market median | 2.2× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on WAT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement